- E-postEva.Gerdts@uib.no
- Telefon+47 55 97 30 54
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- PostadressePostboks 78045020 Bergen
Hjertesykdom hos kvinner er vårt overbyggende forskningsfokus. Hjertesykdom hos kvinner undersøkes i samarbeid med internasjonale partnere i Tyskland, Italia og USA. Hovedfokus er hjertesykdom som følge av høyt blodtrykk, aortaklaffestenose, fedme og autoimmune sykdommer, og hvordan disse faktorene belaster hjertet ulikt hos kvinner og menn. Vår forskning har bidratt til nye europeiske anbefalinger om behandling av høyt blodtrykk hos pasienter med aortaklaffstenose, og et internasjonalt fokus på hjertesykdom hos kvinner. Dette forsker vi på i norske befolkningsundersøkelser og i prosjekter med kliniske studier av personer med høyt blodtrykk, fedme, aortaklaffestenose, autoimmune sykdommer eller iskemisk hjerneslag. Et nytt Senter for forskning på hjertesykdom hos kvinner ble opprettet ved UiB juni 2020 finansiert av Hjertefondet ved UiB, Bergen Sanitetskvinner/Norske Kvinners Sanitetsforening og Grieg Foundation (https://www.uib.no/kvinnehjerte). Vår videre forskning vil tilknyttes Senterets nettverk.
Helseundersøkelsen i Hordaland - runde 3 (HUSK3) ble gjennomført 2018-22. Hovedfokus er hva blodtrykk og andre helsefaktorer og endring i disse mens man er i 40-årene betyr for hjerte-kar helsen 20 år senere. Prosjektet er et samarbeid mellom 4 forskergrupper på UiB ledet av henholdsvis professor Grethe S. Tell, professor Ottar Nygård, professor Jutta Dierkes, undertegnede, BEVITAL akademisk laboratorium og Høgskolen på Vestlandet ved professor Marjolein Iversen. Se også: stipendiat Ester Kringeland, UiB og stipendiat Annabel E. Ohldieck, UiB og deres banebrytende publikasjoner.
Ukontrollert høyt blodtrykk er et stort helseproblem i Norge. I samarbeid med de 4 øvrige universiteter forsker vi på dette i IDA studien. I samarbeid med overlege PhD Marianne Grytaas, endokrinologisk seksjon, medisinsk avdeling, Haukeland Universitetssykehus forsker vi på pasienter med primær aldosteronisme som underliggende årsak til høyt blodtrykk. Vårt hovedfokus er hvordan ukontrollert høyt blodtrykk påvirker hjertet, og om påvirkningen er forskjellig hos kvinner og menn eller utfra hva årsaken til det høye blodtrykket er. Se også: stipendiat Arleen Aune, UiB
Kvinner med autoimmune sykdommer har høy risiko for å få hjertesykdom tidlig. I samarbeid med revmatologisk avdeling, Haukeland Universitetssykehus studerer vi hjerteeffekten av moderne immunmodulerende behandling ved leddgikt. Se også: seniorforsker Helga Midtbø PhD, UiB og Haukeland Universitetssykehus, og stipendiat Anja G. Linde, UiB
Subklinisk hjertekarsykdom hos unge slagpasienter undersøkes i NOR-SYS prosjektet i samarbeid med professor Ulrike Waje-Andreassen, nevrologisk avdeling, Haukeland Universitetssykehus som ble startet i 2010. Oppfølgingsundersøkelsene ved Hjerteavdelingen ble fullført 2022. Hjerteultralydbilder fra den europeiske studien SECRETO på slagpasienter under 50 år sendes for analyse i våre kjernelaboratorium. Se også stipendiat Rune Eilertsen, UiB som er tilknyttet prosjektet.
Kommentar til Kildens rapport om manglende kjønnsperspektiv i norsk hjerteforskning
https://kjonnsforskning.no/nb/2023/01/medisinske-studier-ser-bort-fra-kj...
Høyt blodtrtykk farligere for kvinnehjertet VG oppslag
Tildeling av Nasjonalforeningens hjerteforskningspris 2022
https://forskning.no/demens-forskningspriser-hjernen/kongen-delte-ut-forskningspriser/2018501
Oppslag i Samfunnsviteret 25.05.21
– Data som er samlet inn om menn kan ikke, og bør ikke, gjelde for kvinner – Samfunnsviteren
Kronikk Bergens Tidende 05.07.20
https://www.bt.no/btmeninger/debatt/i/6jxy13/kampen-om-kvinnehjertetIntervju Undervisning i kvinnehelse i utdanning av helsearbeidere Dagsnytt 18, 16.04.20
https://tv.nrk.no/serie/dagsnytt-atten-tv/202004/NNFA56041620/avspiller
Intervju Ensomhet og kvinnehjertehelse Gro Holm NRK P1
https://radio.nrk.no/serie/holm/DMTO01024519
Hjertepraten, Litteraturhuset i Bergen 15.08.18
– Store kjønnsforskjeller ved hjerteinfarkt
Menn og kvinner har forskjellige risikofaktorer, symptomer og typer hjerteinfarkt, påpeker professor Eva Gerdts ved Klinisk institutt 2. Onsdag 15. august holder hun foredrag om temaet på Litteraturhuset i Bergen. Se innlegget på https://www.uib.no/med/119381/–-store-kjønnsforskjeller-ved-hjerteinfarkt eller på https://www.youtube.com/watch?v=t2lwuNonhOA.
https://forskning.no/nasjonal-kompetansetjeneste-for-kvinnehelse-kjonn-o...
Kvinnehjerter - en fagbok om vanlige hjertesykdommer
Løchen ML og Gerdts E. 2015, Oslo (Gyldendal Akademisk). ISBN: 978-8-205-46397-4. Boken kan bestilles ved å sende SMS med kodeord kvinnehjerter til 2030. Pris NOK 425
Underviser i profesjonsutdanning av leger ved UiB, semester MED5, MED11 og MED12. Undervisningen omfatter et praktisk kurs i hjerteultralydundersøkelse med håndholdt ultralydapparat, og forelesninger om høyt blodtrykk, hypertertensiv hjertesykdom og hjertesykdom hos kvinner. Organiserer fagdager om hjerteklaffsykdom hos eldre og symptomet tungpust.
PhD kurs NORHEART901 Cardiovascular imaging in research. Kursleder.
Underviser på nasjonale kurs i spesialistutdanning i indremedisin, nyresykdommer og hjertesykdommer
- (2022). Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypertensive patients. The LIFE Study. Exploration of medicine. 128-138.
- (2022). Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study. Exploration of medicine. 160-172.
- (2020). Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study. Blood Pressure. 267-275.
- (2019). Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study . European Heart Journal. 1554-1562.
- (2019). Impact of obesity on persistent left Ventricular hypertrophy after aortic valve replacement for aortic stenosis. American Journal of Cardiology. 942-947.
- (2019). Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. International Journal of Cardiology. 1-5.
- (2019). Impact of aortic stiffness on myocardial ischaemia in non-obstructive coronary artery disease. Open heart. 1-7.
- (2019). Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis. Heart. 1-6.
- (2018). Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis . Arthritis care & research. 1276-1283.
- (2018). Covariables and types of abnormal left ventricular geometry in nonelderly ischemic stroke survivors: The Norwegian Stroke in theYoung Study. Journal of Hypertension. 1858-1864.
- (2018). Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. Journal of Rheumatology. 1249-1255.
- (2017). Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications. European Heart Journal-Cardiovascular Imaging. 404-412.
- (2017). Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design. European Stroke Journal. 116-125.
- (2017). Masked hypertension in obesity: Potential predictors and arterial damage. Blood Pressure Monitoring. 12-17.
- (2017). Lower transaortic flow rate is Associated with increased mortality in aortic valve stenosis. JACC Cardiovascular Imaging. 912-920.
- (2017). Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania salute network). Journal of the American Heart Association (JAHA). 1-16.
- (2017). Influence of left ventricular stroke volume on incident heart failure in a population with preserved ejection fraction (from the Strong Heart Study). American Journal of Cardiology. 1047-1052.
- (2017). Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. Heart. 1443-1448.
- (2017). Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. Heart. 1619-1624.
- (2017). Does fitness improve the cardiovascular risk profile in obese subjects? NMCD. Nutrition Metabolism and Cardiovascular Diseases. 518-524.
- (2017). Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). International Journal of Cardiology. 260-264.
- (2017). Comparison of frequency of ischemic cardiovascular events in patients with aortic stenosis with versus without asymmetric septal hypertrophy (from the SEAS Trial). American Journal of Cardiology. 1082-1087.
- (2016). The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. Blood Pressure. 298-304.
- (2016). Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome. Clinical and Experimental Rheumatology. 1006-1012.
- (2016). Prevalence and covariates of masked hypertension in ischemic stroke survivors: the Norwegian Stroke in the Young Study. Blood Pressure Monitoring. 244-250.
- (2016). Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy: the LIFE study. Blood Pressure. 150-155.
- (2016). Giant right ventricular outflow tract thrombus in heriditary spherocytosis: a case report. Thrombosis Journal. 1-5.
- (2016). Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. European Heart Journal. 24-34.
- (2016). Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 371-376.
- (2016). Covariates of non-dipping and elevated night-time blood pressure in ischemic stroke patients: the Norwegian Stroke in the Young Study. Blood Pressure. 212-218.
- (2016). Aortic root dimension and arterial stiffness in arterial hypertension: The Campania Salute Network. Journal of Hypertension. 1109-1114.
- (2015). Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Heart. 209-214.
- (2015). Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. Circulation Cardiovascular Imaging.
- (2015). Obesity-associated metabolic changes influence resting and peak heart rate in women and men. Scandinavian Cardiovascular Journal. 337-343.
- (2015). Myocardial function in aortic stenosis - insights from radial multilayer Doppler strain. Cardiovascular Ultrasound. 8 sider.
- (2015). Left ventricular wall stress-mass-heart rate product and cardiovascular events in treated hypertensive patients: Life study. Hypertension. 945-953.
- (2015). Global coronary artery plaque area is associated with myocardial hypoperfusion in women with non-ST elevation myocardial infarction. Journal of Women's Health. 367-373.
- (2015). Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology. 511-519.
- (2015). Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. Scientific Reports.
- (2014). Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. Heart. 1946-1953.
- (2014). Relationship of levt ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the Development of New heart failure. Journal of Hypertension. 2472-2478.
- (2014). Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania. Blood Pressure. 21-38.
- (2014). Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis. Heart. 28-33.
- (2014). Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. American Journal of Cardiology. 1532-1535.
- (2014). Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study). Blood Pressure. 206-212.
- (2014). Iatrogenic external pudendal artery pseudoaneurysm with a communicating arteriovenous fistula - A diagnostic and therapeutic pitfall. Echocardiography. E158-E160.
- (2014). Four-group classifcation of left ventricular hypertrophy based on ventricular concentricity and dilatation identifes a low-risk subset of eccentric hypertrophy in hypertensive patients. Circulation Cardiovascular Imaging. 422-429.
- (2014). Early vascular aging in young and middle-aged ischemic stroke patients: The Norwegian stroke in the young study. PLOS ONE.
- (2014). Determinants of systolic blood pressure response during exercise in overweight subjects. Blood Pressure. 200-205.
- (2014). Adjusting parameters of aortic valve stenosis severity by body size. Heart. 1024-1030.
- (2013). The Norwegian stroke in the young study (NOR-SYS): rationale and design. BMC Neurology. 12 sider.
- (2013). Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension. 2060-2068.
- (2013). Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. Current problems in cardiology. 365-409.
- (2013). Left atrial volume as predictor of valve replacement and cardiovascular events in patients with asymptomatic mild to moderate aortic stenosis. Echocardiography. 1008-1014.
- (2013). Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis. Journal of the American College of Cardiology. 1683-1690.
- (2010). Myocardial deformation in aortic valve stenosis – relation to left ventricular geometry. Heart. 106-112.
- (2010). Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in aortic stenosis [SEAS] substudy). American Journal of Cardiology. 1456-1460.
- (2010). Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). Blood Pressure. 140-144.
- (2010). Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension. 1134-1140.
- (2010). An unusual location of a papillary fibroelastoma. European Heart Journal-Cardiovascular Imaging.
- (2009). Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. Echocardiography. 52-60.
- (2009). Left ventricular long-axis function in treated haemochromatosis. The International Journal of Cardiac Imaging. 237-247.
- (2009). Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 634-640.
- (2008). Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania. Cardiovascular Journal of Africa. 8-14.
- (2008). Left ventricular structure in different types of chronic pressure overload. European Heart Journal, Supplement. E23-E30.
- (2008). Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Hypertension. 1472-1476.
- (2008). Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). European Heart Journal-Cardiovascular Imaging. 809-815.
- (2008). Gender differences in left ventricular structure and function during antihypertensive treatment - The Losartan intervention for Endpoint reduction in hypertension study. Hypertension. 1109-1114.
- (2008). Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy in Response to Antihypertensive Therapy. Hypertension. 100-106.
- (2008). Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS substudy). American Journal of Cardiology. 510-515.
- (2008). Effects of Losartan in women with hypertension and left ventricular hypertrophy results from the Losartan Intervention For Endpoint Reduction in hypertension study. Hypertension. 1103-1108.
- (2008). Clinical impact of ' in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Hypertension. 806-812.
- (2007). Reduced exercise capacity in genetic haemochromatosis. European Journal of Cardiovascular Prevention & Rehabilitation. 470-475.
- (2007). Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. American Journal of Hypertension. 771-776.
- (2006). Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy - The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. Circulation. 1588-1596.
- (2006). Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Blood Pressure. 220-226.
- (2005). Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Journal of the American College of Cardiology. 705-711.
- (2005). Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Journal of the American College of Cardiology. 712-719.
- (2000). Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. American Heart Journal. 624-630.
- (2000). Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. Journal of Hypertension. 1129-1138.
- (2000). Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. American Journal of Cardiology. 466-472.
- (2000). Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. Hypertension. 6-12.
- (2000). HOPE ett år senere. Hjerteforum. 31-35.
- (1999). Similar central hemodynamics in salt sensitive and salt resistant hypertensive patients. Blood Pressure. 233-241.
- (1999). Reproducibility of salt sensitivity testing using a dictary approach in essential hypertension. Journal of Human Hypertension. 375-384.
- (1999). Early complications and long-term mortality after urgent or routine coronary angioplasty. Scandinavian Cardiovascular Journal. 33.
- (1998). The Bergen Blood pressure Study: changes in cardiac structure and function in offspring of hypertensive families. European Heart Journal. 474-474.
- (1998). Is salt sensitivity a temporary phenomenon? Journal of Hypertension. 150-150.
- (1998). Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy. The LIFE. Circulation. 1-205.
- (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for months months. American Journal of Hypertension. 1178-1187.
- (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. American Journal of Hypertension. 1178-1187.
- (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. American Journal of Hypertension. 1178-1187.
- (1998). Factors Influencing Left Ventricular Mass in Salt Sensitive and Salt Resistant Essential Hypertensive Patients. Blood Pressure. 223-230.
- (1998). Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney International. 1455-1460.
- (1997). Regression of left ventricular hypertrophy in type-1 diabetic patients using doxazosin as antihypertensive therapy @<abstract@>. Journal of Hypertension. 40.
- (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. Blood Pressure. 197-202.
- (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. Blood Pressure. 197-202.
- (1997). Angiotensin converting enzyme inhibition and alpha<SUB>1</SUB>-receptor blockade as antihypertensive therapy in type-1 diabetic patients. American Journal of Hypertension. 121A.
- (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. Blood Pressure. 78-85.
- (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. Blood Pressure. 78-85.
- (1996). Factors influencing left ventricular mass in hypertensive type-1 diabetic patients. American Journal of Hypertension. 65A.
- (1994). Salt sensitive essential hyperdension evaluated by 24 hour ambulatory blood pressure. Blood Pressure. 375-380.
- (1994). Salt sensitive essential hyperdension evaluated by 24 hour ambulatory blood pressure. Blood Pressure. 375-380.
- (1994). Postoperative Doppler echocardiograpic evaluation in different sizes of Medtronic-Hall, Biocor and Carpentier-Edwards s.a.v. prosthetic-aortic valves. Scandinavian journal of thoracic and cardiovascular surgery. 25-29.
- (2018). Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study.
- (2018). Long-term systolic blood pressure trajectories and incident atrial fibrillation in women and men: The Tromsø Study.
- (2003). Left atrial size and risk of major cardiovascular events in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial).
- (2002). The impact of concomitant diabtes on changes in left ventricular structure and function during antihypertensive treatment (the LIFE study).
- (2002). Endocardial as well as midwll fractional shortening predict cardiovascular outcome in hypertension: The LIFE study.
- (2001). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the LIFE study.
- (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension.
- (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension.
- (2000). Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy.
- (2000). Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy.
- (2000). Parallel cardiac and renal damage in patients with left ventricular hypertrophy.
- (2000). Parallel cardiac and renal damage in patients with left ventricular hypertrophy.
- (2000). Inappropriate left ventricular mass is associated with high cardiovascular risk profile in hypertensive subjects.
- (2000). Inappropriate left ventricular mass is associated with high cardiovascular risk profile in hypertensive subjects.
- (2000). In hypertensive patients with left ventricular hypertrophy inappropriate left ventricular mass identifies high risk phenotypes.
- (2000). In hypertensive patients with left ventricular hypertrophy inappropriate left ventricular mass identifies high risk phenotypes.
- (2000). Change in diastolic left ventricular function after one year of antihypertensive treatment.
- (2000). Change in diastolic left ventricular function after one year of antihypertensive treatment.
- (2000). Antihypertensive therapy has greater impact on left ventrular hypertrophy reduction in women than men.
- (2000). Antihypertensive therapy has greater impact on left ventrular hypertrophy reduction in women than men.
- (1997). Hypertensive women with electrocardiographic left ventricular hypertrophy have Doppler echocardiographic indications of more impaired diastolic left ventricular function compared to men, at rest and during exercise.
- (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus.
- (1996). Factors influencing left ventricular mass in hypertense type-1 diabetic patients.
- (1995). Factors influencing the regression of left ventricular mass in men and women operated for aortic stenosis.
- (1994). Plasma atial natriuretic peptide in salt sensitive hypertensive patients.
- (2022). Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypersensitive patients. Journal of Hypertension. e3-e3.
- (2022). SEX DIFFERENCES IN ARTERIAL FUNCTION IN OBESITY: THE FAT-ASSOCIATED CARDIOVASCULAR DYSFUNCTION STUDY. Journal of Hypertension. e270-e270.
- (2022). Implications of CYP2D6 polymorphisms for therapeutic drug monitoring in patients with hypertension. Journal of Hypertension. e310.
- (2020). Sex-specific temporal trends in the incidence of atrial fibrillation in a large Norwegian population-based study 1986–2014. European Heart Journal. 509-509.
- (2018). 6168 Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study. European Heart Journal. 1275-1276.
- (2014). Determinants of left ventricular systolic function after transcatheter aortic valve implantation. European Heart Journal-Cardiovascular Imaging.
- (2013). Outcome in 1763 asymptomatic patients with mild or moderate calcific aortic stenosis followed prospectively with annual echocardiography. European Heart Journal. 334-334.
- (2013). Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment in patients with electrocardiographic left ventricular hypertrophy (LIFE). European Heart Journal. 597-597.
- (2013). Hypertensive target organ damage predicts incident diabetes mellitus. European Heart Journal. 3419-3426.
- (2013). Does rheumatoid arthritis predispose to abnormal left ventricular geometry independent of hypertension? European Heart Journal. 754-754.
- (2013). Disease Activity In Rheumatoid Arthritis Is Associated With Abnormal Left Ventricular Geometry. Arthritis and Rheumatism. S182-S182.
- (2013). Coronary artery plaque burden is a predictor of myocardial ischemia in non-ST elevation myocardial infarction in both genders. European Heart Journal. 74-75.
- (2013). Arterial Stiffness Is Associated With Abnormal Left Ventricular Geometry In Patients With Rheumatoid Arthritis. Arthritis and Rheumatism. S174-S175.
- (2012). Midwall left ventricular systolic function in asymptomatic aortic valve stenosis: is it prognostically important? The SEAS study. European Heart Journal. 97-98.
- (2012). Covariates of global longitudinal strain and displacement in type 2 diabetes: a speckle tracking echocardiography study. European Heart Journal. 454-454.
- (2011). Increased systolic strain rate early after transcatheter aortic valve implantation. European Heart Journal-Cardiovascular Imaging. ii37-ii37.
- (2011). Impact of valvuloarterial impedance on cardiovascular outcome in patients with asymptomatic aortic stenosis. The SEAS study. Circulation.
- (2011). Impact of aortic valve stenosis and hypertension on radial strain in multiple layers. European Heart Journal, Supplement. 1008-1009.
- (2010). Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study). European Heart Journal. 886-887.
- (2010). Left ventricular mass, an independent predictor of morbidity and mortality in aortic valve stenosis. European Heart Journal. 887-887.
- (2010). Increased Relative Wall Thickness - A Frequent Marker of Subclinical Cardiac Target Organ Damage in African Diabetic Patients. Journal of Hypertension. E357-E357.
- (2010). Hypoperfusion by contrast echocardiography predicts coronary artery disease severity in non-ST elevation myocardial infarction. European Heart Journal. 914-914.
- (2010). Hypokalemi blunts left ventricular mass regression in hypertensive patients during losartan- or atenolol-based treatmend: The LIFE echo-substudy. Journal of Hypertension. E442-E443.
- (2010). COMBINED USE OF ELECTROCARDIOGRAM AND ECHOCARDIOGRAM TO BETTER IDENTIFY HYPERTENSIVE PATIENTS AT HIGH RISK FOR HEART FAILURE. Journal of Hypertension. E214-E214.
- (2009). Relation of degree of aortic valve calcification to left ventricular geometry and systolic function in asymptomatic aortic valve stenosis: A SEAS substudy. Journal of the American College of Cardiology. A410-A410.
- (2009). Outcome of Asymptomatic Patients With Low Gradient "Severe" Aortic Valve Stenosis and Preserved Ejection Fraction - Results From the Prospective SEAS Study. Circulation. S371-S371.
- (2009). Impact of severity of aortic valve stenosis on effect of intensive lipid-lowering therapy: The SEAS study. Journal of the American College of Cardiology. A415-A415.
- (2009). ISOLATED SYSTOLIC HYPERTENSION IN PATIENTS WITH ASYMPTOMATIC AORTIC STENOSIS (A SEAS SUBSTUDY). Journal of Hypertension. S248-S248.
- (2009). IMPACT OF STROKE VOLUME ON CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY (A LIFE SUBSTUDY). Journal of Hypertension. S319-S320.
- (2009). Gender Differences in Outcome During Antihypertensive Therapy in Relation to Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study. Circulation. S1111-S1111.
- (2009). Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substudy. Circulation. S1164-S1165.
- (2009). Compensatory or inappropriate left ventricular mass in asymptomatic aortic stenosis. Journal of the American College of Cardiology. A408-A409.
- (2009). 2D Longitudinal Myocardial Strain: A More Sensitive Parameter of Left Ventricular Dysfunction in Aortic Valve Stenosis? Circulation. S372-S373.
- (2008). The differential impact of static and pulsatile blood pressure components on regional myocardial deformation in patients with asymptomatic aortic valve stenosis. A SEAS substudy. Journal of Hypertension. S255-S256.
- (2008). Impact of global afterload on left ventricular myocardial contractility in asymptomatic aortic stenosis: A SEAS substudy. Journal of the American College of Cardiology. A380-A380.
- (2008). Impact of Pressure Recovery on Diagnosis of Severe Aortic Stenosis In Asymptomatic Patients. (A SEAS Substudy). Circulation. S931-S931.
- (2008). Gender differences in left ventricular structure and function during antihypertensive treatment (the LIFE study). Journal of Hypertension. S275-S275.
- (2007). Relationship of left ventricular Systolic function to persistence or development,of Electrocardiographic left ventricular hypertrophy in hypertensive patients: Implications for the development of new heart failure. Circulation. 473-473.
- (2007). Pulse pressure - An independent predictor of left ventricular hyperthrophy in patients with asymptomatic aortic stenosis. A SEAS substudy. Circulation. 671-671.
- (2007). Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during anti-hypertensive treatment: The LIFE echo-substudy. Circulation. 498-498.
- (2007). Impact of left ventricular geometry on stress-corrected left ventricular systolic function in asymptomatic aortic valve stenosis. A SEAS substudy. Journal of the American College of Cardiology. 298A-299A.
- (2007). Gender difference in the association of aortic valve sclerosis and cardiovascular events in hypertensive adults with left ventricular hypertrophy: The LIFE study. Circulation. 735-735.
- (2007). Does metabolic syndrome influence reduction of ECG left ventricular hypertrophy? The LIFE study. Journal of Hypertension. S78-S78.
- (2007). Association of aortic regurgitation with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: The LIFE study. Circulation. 735-735.
- (2006). Relationship of left atrial enlargement to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. Circulation. 366-366.
- (2006). Prevalence and covariates of low left ventricular midwall shortening in patients with asymptomatic aortic valve stenosis. A SEAS substudy. Circulation. 656-657.
- (2006). Impact of gender on left atrial and ventricular response to asymptornatic aortic valve stenosis. The SEAS study. Journal of the American College of Cardiology. 285A-286A.
- (2005). Relationship of electrocardiographic strain pattern to left ventricular diastolic function in hypertensive patients: The LIFE study. Journal of the American College of Cardiology.
- (2005). Influence of hypertension on angiographic findings in patients with angina pectoris. American Journal of Hypertension. 175A.
- (2005). Impact of concomitant hypertension on left ventricular structure in patients with aortic valve stenosis. The SEAS study. European Heart Journal-Cardiovascular Imaging. S76.
- (2005). Echocardiographic determinants of new-onset atrial fibrillation in patients with hypertension and electrocardiographic left ventricular hypertrophy: The LIFE study. Journal of the American College of Cardiology.
- (2004). Tissue Doppler findings in patients with genetic hemochromatosis. Hjerteforum. 101.
- (2004). Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Trial). Journal of the American College of Cardiology. 448A.
- (2004). Myocardial performance index independently predicts cardiovascular morbidity and mortality in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Journal of the American College of Cardiology. 227A.
- (2004). Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Journal of the American College of Cardiology. 357A.
- (2004). Ethnicity, left ventricular hypertrophy regressio and cardiovascular events in the LIFE echocardiography substudy. American Journal of Hypertension. A195.
- (2004). Does losartan improve diastolic left ventricular function beetter than atenolol during more then four years of antihypertensive treatment? The LIFE Study. Circulation. 637.
- (2004). Clinical and echocardiographic risk factors for congestive heart failure in controlled hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Study). Circulation. 682-682.
- (2004). Blood pressure and cardiovascular risk factors in hypertensive patients referred to a regional hospital in Ghana. American Journal of Hypertension. A196.
- (2022). Sex differences in arterial hypertension. European Heart Journal. 4777-4788.
- (2022). New Evidence About Aortic Valve Stenosis and Cardiovascular Hemodynamics. High Blood Pressure & Cardiovascular Prevention. 231-237.
- (2022). Grading of Aortic Stenosis: Is it More Complicated in Women? European Cardiology. 5 sider.
- (2021). Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: Position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research (CVR). 367-385.
- (2020). Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy.
- (2019). Sex differences in cardiometabolic disorders. Nature Medicine. 1657-1666.
- (2018). Managing complications of hypertension in aortic valve stenosis patients. Expert Review of Cardiovascular Therapy. 897-907.
- (2016). Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic. Expert Review of Cardiovascular Therapy. 915-926.
- (2016). Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. Clinical and Experimental Rheumatology. 133-142.
- (2013). Left ventricular geometry in obesity: Is it what we expect? NMCD. Nutrition Metabolism and Cardiovascular Diseases. 905-912.
- (2010). Impact of ultrasound contrast agents in echocardiographic assessment of ischemic heart disease. Recent patents on cardiovascular drug discovery. 103-112.
- (2004). Essential hypertension in women. Blood Pressure. 272-278.
FEMALE HEART project (kvinnehjerteprosjektet)
Prosjektet startet i 2012 som et samarbeid mellom vår forskergruppe og forskergrupper ved Norges arktiske universitet i Tromsø og Federico II Universitetet i Napoli, Italia. Prosjektet er translasjonelt og omfatter både dyreeksperimentelle og kliniske studier. Fokus er å forstå hvorfor høyt blodtrykk er mer skadelig for kvinnehjertet, og nye metoder for tidlig påvisning av slik hjerteskade. Prosjektet pågår fortsatt. En årlig Female Heart workshop arrangeres ved UiB for å spre ny kunnskap fra prosjektet.
Helseundersøkelsen i Hordaland - 3. runde (HUSK3)
Ble gjennomført 2018-22. Fokus på hvordan høyt blodtrykk i 40 årene påvirker kvinner og menns helse når de er 20 år eldre. Oppfølging av 2192 personer. Prosjektet er et samarbeid mellom 5 forskergrupper ved UiB og Helse-Bergen.
Fedmeassosiert hjertekardysfunksjon (FATCOR)
Fokus på hvordan fedme påvirker hjertets- og pulsårenes funksjon hos kvinner og menn. Tverrsnittsundersøkelse av 618 friske personer med fedme. Prosjektet er et samarbeid mellom 5 forskergrupper ved UiB og Helse-Bergen. En oppfølgingsundersøkelse av deltakerne starter 2022. Fokus er endring av blodtrykk midt i livet, hvilke faktorer som har betydning for at blodtrykket stiger, og kartlegging av underliggende mekanismer.
Norwegian Stroke in the Young Studien (NORSYS) - 5 års studien
Studien er et samarbeid mellom forskere ved nevrologisk avdeling og hjerteavdelingen, Haukeland Universitetssykehus og Klinisk institutt 2. Prosjektet startet i 2010 og 385 pasienter ble rekruttert i perioden 2010-15. Disse ble invitert til en substudie hvor blodtrykk og arteriestivhet ble kontrollert påny etter 5 år.